PGD2 receptor antagonists for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2005233125 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Ghosh, Shomir; Renou, Christelle C.; Elder, Amy M.; Hicks, Frederick A.; Reynolds, Dominic; Carson, Kenneth G.; Harrison, Sean J.; Sprott, Kevin T.

Agent Davies Collison Cave

Pub. Number AU-A-2005233125

PCT Pub. Number WO2005/100321

Priority 60/560,410 07.04.04 US

Filing date 7 April 2005

Wipo publication date 27 October 2005

International Classifications

C07D 215/44 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/100321 Priority application(s): WO2005/100321

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005233128-Bazedoxifene ascorbate as selective estrogen receptor modulator

2005233121-Method and apparatus for compression molding plastic articles